TARGET ENGAGEMENT IN A PHASE II CLINICAL TRIAL OF AAV2-NGF GENE THERAPY FOR ALZHEIMER’S DISEASE
| Autor: | Castle, Michael J. 1, Baltanas, Fernando Calvo 1, Kovacs, Imre 1, Nagahara, Alan H. 1, Bankiewicz, Krystof S. 2, Barba, David 1, Tuszynski, Mark H. 1, 3 |
|---|---|
| Zdroj: | In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2018 14(7) Supplement:P677-P677 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|